Cambridge, United Kingdom · Founded 2003 · Privately Held (backing)
Manufacturer of genomic diagnostic tests designed to detect and monitor gastrointestinal diseases. Origin (Diagnostic Equipment) is based in Cambridge, United Kingdom and was founded in 2003. Its last reported valuation was $165 million in Dec 2024. It has raised $39 million.
Last reported valuation
$165.2M
Oct 2026
Priced at
—
Total raised
$39.0M
Last round
—
No prints on record
No secondary trades in Origin (Diagnostic Equipment) shares have been recorded yet. When market activity lands it appears here as monthly aggregates and, for platform-recorded trades, dated prints.
Pro members can request priority coverage with a 48-hour turnaround.
Private Market View
More of Origin (Diagnostic Equipment) with a free Private Market View account
·Watch Origin (Diagnostic Equipment): the Monday email on marks, rounds and moves
Where Origin (Diagnostic Equipment) prices come from
Secondary marks are indicative month-end price levels observed across secondary-market trading venues — a level, not a trade — and are the market input to the PrivateMarketView mark. Private share prices aren’t published anywhere. Aggregate figures combine multiple reporting channels — direct participant reports, platform transactions, third-party market intelligence — at monthly granularity. Individually dated prints are a Pro feature and are shown only for transactions recorded on our own platform. Third-party-reported trades are never republished individually, at any tier. Verified prints (✓) have been confirmed against a second source. Prints marked SPV or Forward reflect the structure’s pricing, which can differ from direct share transfers of Origin (Diagnostic Equipment) stock.
